Gene cell therapy combined with stem cells may be a potential future advancement

June 29, 2011 - PRLog -- Researchers at the Salk Institute for Biological Studies in La Jolla, California, successfully edited diseased genes in patient-specific induced pluripotent stem cells as well as adult stem cells.  The study will be published in the June 3, 2011 issue of Cell Stem Cell.

The gene-editing approach developed by Salk professor, Juan Carlos Izpisua Belmonte, PhD and associates provides a safe and efficient way for cell engineering, and opens the way for more gene edited combined stem cell therapies for clinical applications.  

Dr. Dennis Lox, a physical and regenerative medicine specialist in the Tampa Bay area of Florida, comments that the edition of gene-based therapy in conjunction with stem cells provides a potential method of treating previously incurable diseases.  

“The research currently underway at Salk is groundbreaking,” said Dr. Lox.  “It has exciting potential in the treatment of rare disorders.”


A summary of the study in the June 3, 2011 issue of Cell Stem Cell can be found at:
http://www.cell.com/cell-stem-cell/fulltext/S1934-5909(11...

http://www.DrLox.com

# # #

Dennis M. Lox, M.D. is board certified in Physical Medicine and Rehabilitation. Since 1990, he has used sports medicine techiques and cutting-edge technology to help heal musculoskeletal injuries and relieve pain.